This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflec... This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflecting clarifications and updates resulting from the Q&A review

This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflec... This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflecting clarifications and updates resulting from the Q&A review

The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated ... The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated molecular diagnostic testing using NGS to improve the evaluation and management of thyroid nodules with indeterminate FNA cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk.

The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated ... The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated molecular diagnostic testing using NGS to improve the evaluation and management of thyroid nodules with indeterminate FNA cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk.